Drugs / CLUSTOID
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01012531 Comparator | Oct 2008 → Nov 2009 | allergic rhinitis | Roxall | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLUSTOID | “Efficacy and Safety of Subcutaneous Cluster Immunotherapy With Cluster-allergoid CLUSTOID Grasses/Rye (Glutaraldehyde-polymerized Allergen Extract of Mixtures of Grass and Rye...” NCT01012531 ↗ |
| Known as | Cluster-allergoid CLUSTOID Grasses/Rye | “Efficacy and Safety of Subcutaneous Cluster Immunotherapy With Cluster-allergoid CLUSTOID Grasses/Rye (Glutaraldehyde-polymerized Allergen Extract of Mixtures of Grass and Rye...” NCT01012531 ↗ |
| Route | Subcutaneous | “Subcutaneous injections with highly polymerized allergen extract” NCT01012531 ↗ |